NIALAMIDE AS A "STEROID SPARING" AGENT IN THE TREATMENT OF RHEUMATOID ARTHRITIS.
作者信息
WRIGHT V, WALKER W C, WOOD E A
出版信息
Ann Rheum Dis. 1963 Sep;22(5):348-53. doi: 10.1136/ard.22.5.348.
Abstract
摘要
相似文献
1
NIALAMIDE AS A "STEROID SPARING" AGENT IN THE TREATMENT OF RHEUMATOID ARTHRITIS.尼亚酰胺作为一种“激素节省”剂用于类风湿关节炎的治疗。
Ann Rheum Dis. 1963 Sep;22(5):348-53. doi: 10.1136/ard.22.5.348.
2
INTRAMUSCULAR ADMINISTRATION OF STEROIDS IN TREATMENT OF RHEUMATOID ARTHRITIS.肌肉注射类固醇治疗类风湿关节炎
Ann Rheum Dis. 1964 Nov;23(6):456-62. doi: 10.1136/ard.23.6.456.
3
CLINICAL TRIALS WITH TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS. PRELIMINARY REPORT.
Arch Interam Rheumatol. 1964 Mar;7:93-103.
4
5
[CLINICAL ASPECTS AND THERAPY OF STEROID DIABETES].[类固醇糖尿病的临床特征与治疗]
Dtsch Med Wochenschr. 1964 Nov 6;89:2130-6. doi: 10.1055/s-0028-1113249.
6
SIDE-EFFECTS OF LONG-TERM TREATMENT WITH CORTICOSTEROIDS AND CORTICOTROPHIN.皮质类固醇和促肾上腺皮质激素长期治疗的副作用
Lancet. 1964 May 23;1(7343):1121-3. doi: 10.1016/s0140-6736(64)91804-5.
7
STEROID CATARACTS. POSTERIOR SUBCAPSULAR CATARACT FORMATION IN RHEUMATOID ARTHRITIS PATIENTS ON LONG TERM STEROID THERAPY.类固醇性白内障。长期接受类固醇治疗的类风湿关节炎患者后囊下白内障的形成。
Arch Ophthalmol. 1965 Jul;74:38-41. doi: 10.1001/archopht.1965.00970040040009.
8
DIFFUSE PULMONARY GRANULOMATOSES AND FIBROSES.弥漫性肺肉芽肿和纤维化。
Mod Treat. 1964 Mar;1:290-306.
9
CLINICAL TRIAL OF P-1742 TOPICAL OR FLUPEROLONE (9 FLUORO-21 METHYL PREDNISOLONE) IN PSORIASIS.P-1742外用剂或氟哌啶醇（9-氟-21-甲基泼尼松龙）治疗银屑病的临床试验。
Singapore Med J. 1964 Jun;4:69-72.
10
CATARACT DUE TO ORAL STEROID THERAPY IN A PATIENT WITH RHEUMATOID ARTHRITIS.
Med J Aust. 1964 Jul 18;2:96-7. doi: 10.5694/j.1326-5377.1964.tb128122.x.
本文引用的文献
1
The effects of iproniazid and other amine oxidase inhibitors in rheumatoid arthritis.异烟酰异丙肼及其他胺氧化酶抑制剂对类风湿性关节炎的作用。
Ann N Y Acad Sci. 1959 Sep 17;80:820-34. doi: 10.1111/j.1749-6632.1959.tb49258.x.
2
[Clinico-therapeutic evaluation of a new inhibitor of monoamine oxidase, nialamide].
Minerva Med. 1959 Dec 26;50:4447-53.
3
[Preliminary study on the clinical effects of a new monoamine oxidase antagonist in rheumatoid arthritis].[一种新型单胺氧化酶拮抗剂治疗类风湿关节炎的临床疗效初步研究]
Minerva Med. 1959 Dec 26;50:4455-6.
4
[A new monoamine oxidase inhibitor: niamide. Its trial in internal medicine].一种新型单胺氧化酶抑制剂：尼亚酰胺。其在内科的试验
Sem Med Prof Med Soc. 1961 Mar 20;37:989-91.
5
[The significance of Niamide in the treatment of rheumatic diseases].
Wien Med Wochenschr. 1961 May 27;111:353-5.
6
Some factors modifying the expression of human strength.一些影响人类力量表现的因素。
J Appl Physiol. 1961 Jan;16:157-63. doi: 10.1152/jappl.1961.16.1.157.
7
Hepatitis caused by the newer amine-oxidase-inhibiting drugs.由新型胺氧化酶抑制药物引起的肝炎。
Lancet. 1961 Sep 16;2(7203):621-3. doi: 10.1016/s0140-6736(61)90306-3.
8
DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.类风湿关节炎的诊断标准：美国风湿病协会委员会1958年修订版。
Ann Rheum Dis. 1959 Mar;18(1):49-51; French transl 51-2; Spanish transl 52-3.
9
Pathological findings in jaundice associated with iproniazid therapy.与异烟肼治疗相关的黄疸的病理发现。
J Am Med Assoc. 1958 Dec 27;168(17):2235-42. doi: 10.1001/jama.1958.03000170027007.
10
[Disorder of cortisol-noradrenalin homeostasis in chronic evolutive polyarthritis].[慢性进行性多关节炎中皮质醇 - 去甲肾上腺素稳态紊乱]
J Belge Med Phys Rhumatol. 1958 May-Jun;13(3):183-9.
Zotero 插件